Page last updated: 2024-08-21

2-tert-butylhydroquinone and tacrolimus

2-tert-butylhydroquinone has been researched along with tacrolimus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Auld, DS; Austin, CP; Huang, R; Moeller, TA; Sakamuru, S; Shinn, P; Shukla, SJ; Vanleer, D; Xia, M1
Ikebuchi, H; Onose, J; Sawada, J; Teshima, R1

Other Studies

2 other study(ies) available for 2-tert-butylhydroquinone and tacrolimus

ArticleYear
Identification of clinically used drugs that activate pregnane X receptors.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:1

    Topics: Animals; Cell Line, Tumor; Cytochrome P-450 CYP3A; Drug Interactions; Hep G2 Cells; Hepatocytes; Humans; Pharmaceutical Preparations; Pregnane X Receptor; Rats; Receptors, Steroid; Small Molecule Libraries; Species Specificity; Structure-Activity Relationship; Xenobiotics

2011
Ca2+-ATPase inhibitors and PKC activation synergistically stimulate TNF-alpha production in RBL-2H3 cells.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1998, Volume: 47, Issue:8

    Topics: Animals; Calcium-Transporting ATPases; Dactinomycin; Dexamethasone; Enzyme Activation; Enzyme Inhibitors; Hydroquinones; Indoles; Leukemia, Basophilic, Acute; Protein Kinase C; Rats; Tacrolimus; Thapsigargin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1998